Royalty Pharma RPRX
$68.45 +$0.73 (+1.08%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $67.91 -0.79%
Open$68.17
Prev close$67.72
Day range$67.95 – $68.83
Volume3.53M
Market cap$30.48B
P/E (TTM)44.7
Dividend yield1.35%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$690.10M+13.3% YoY
Operating profit$561.20M+31.4% YoY
Net profit$266.64M-39.4% YoY
Diluted EPS$0.32-51.5% YoY
Free cash flow$686.08M-2.4% YoY
Operating cash flow$686.08M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin65.5%
Net margin25.7%
Return on equity10.1%
Return on assets3.5%
Return on invested capital6.6%
Current ratio1.29
Liabilities / assets49.7%
Cash & investments$1.48B
Total debt$8.59B
Net cash (debt)-$7.11B
Free cash flow / sales113.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $690.10M | $674.14M | $630.58M | $2.38B | $621.99M |
| Operating Expense | $128.91M | $541.02M | -$1.91M | $818.68M | $233.61M |
| Selling and Admin Expenses | $150.10M | $161.89M | $159.49M | $573.48M | $164.27M |
| -General & Admin Expense | $150.10M | $161.89M | $159.49M | $573.48M | $164.27M |
| Research & Development | $63.16M | $97.85M | $39.79M | $452.00M | $50.50M |
| Asset Impairment Loss | $3.97M | $13.07M | -$3.70M | $89.03M | -$4.27M |
| Other Operating Expenses | -$88.32M | $268.22M | -$197.49M | -$295.84M | $23.11M |
| Operating Profit | $561.20M | $133.12M | $632.48M | $1.56B | $388.38M |
| Net Non-Operating Interest Income (Expense) | -$85.15M | -$88.49M | -$87.49M | -$274.07M | -$87.10M |
| Non-Operating Interest Income | $5.34M | $5.13M | $6.23M | $33.59M | $7.07M |
| Non-Operating Interest Expense | $90.49M | $93.62M | $93.72M | $307.66M | $94.17M |
| Other Income (Expense) | -$209.41M | $36.86M | -$76.73M | $38.75M | $55.63M |
| Gain on Sale of Security | -$66.39M | $34.28M | -$26.85M | $24.01M | $59.80M |
| Earnings from Equity Interest | $9.23M | $4.08M | $21.76M | $29.09M | $4.01M |
| Special Income (Charges) | -$150.36M | $0.00 | -$69.44M | – | – |
| -Less:Write Off | $150.36M | $0.00 | $69.44M | – | – |
| Other Non-Operating Income (Expenses) | -$1.88M | -$1.50M | -$2.20M | -$14.35M | -$8.17M |
| Pretax Profit | $266.64M | $81.49M | $468.26M | $1.32B | $356.91M |
| Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Profit | $266.64M | $81.49M | $468.26M | $1.32B | $356.91M |
| Profit from Continuing Operations | $266.64M | $81.49M | $468.26M | $1.32B | $356.91M |
| Minority Interests | $121.96M | $63.60M | $173.57M | $553.25M | $141.71M |
| Net Income to Parent Company | $144.68M | $17.88M | $294.69M | $770.95M | $215.21M |
| Net Income to Common Stockholders | $144.68M | $17.88M | $294.69M | $770.95M | $215.21M |
| Basic EPS | $0.32 | $0.04 | $0.67 | $1.79 | $0.50 |
| Diluted EPS | $0.32 | $0.04 | $0.67 | $1.78 | $0.38 |
| Dividend Per Share | $0.24 | $0.24 | $0.24 | $0.88 | $0.22 |
| Total Revenue as Reported | – | $674.14M | – | $2.38B | $621.99M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $19.46B | $19.82B | $19.82B | $19.62B | $19.62B |
| Total Current Assets | $1.53B | $1.76B | $1.43B | $1.53B | $1.53B |
| Cash and Cash Equivalents & Short-Term Investments | $1.48B | $1.73B | $1.39B | $1.49B | $1.49B |
| -Cash and Cash Equivalents | $513.66M | $811.99M | $586.40M | $618.70M | $618.70M |
| -Short Term Investments | $968.08M | $914.45M | $801.74M | $873.19M | $873.19M |
| Receivables | $35.93M | $31.47M | $27.51M | $29.32M | $29.32M |
| -Other Receivables | $35.93M | $31.47M | $27.51M | $29.32M | $29.32M |
| Other Current Assets | $7.90M | $6.66M | $10.16M | $6.89M | $6.89M |
| Total Non-Current Assets | $17.94B | $18.06B | $18.39B | $18.09B | $18.09B |
| Investments and Advances | $16.95B | $17.07B | $17.39B | $17.09B | $17.09B |
| -Available for Sale Securities | $16.69B | $16.81B | $17.12B | $16.80B | $16.80B |
| -Long Term Equity Investment | $262.34M | $261.97M | $265.70M | $289.97M | $289.97M |
| Goodwill and Other Intangible Assets | $923.54M | $923.54M | $924.63M | $924.63M | $924.63M |
| -Goodwill | $923.54M | $923.54M | $924.63M | $924.63M | $924.63M |
| Other Non-Current Assets | $61.57M | $62.96M | $76.85M | $79.29M | $79.29M |
| Total Liabilities | $9.67B | $10.03B | $9.88B | $9.91B | $9.91B |
| Total Current Liabilities | $1.18B | $630.93M | $535.68M | $636.21M | $636.21M |
| Payables | $102.48M | $126.85M | $112.90M | $92.23M | $92.23M |
| -Accounts Payable | $31.42M | $35.57M | $25.48M | $19.40M | $19.40M |
| -Dividends Payable | $71.06M | $91.28M | $87.42M | $72.83M | $72.83M |
| Current Accrued Expenses | $19.69M | $107.77M | $25.30M | $110.82M | $110.82M |
| Short-Term Debt and Capital Lease Obligation | $996.97M | $380.00M | $380.00M | $380.00M | $380.00M |
| -Current Debt | $996.97M | $380.00M | $380.00M | $380.00M | $380.00M |
| Other Current Liabilities | $59.86M | $16.32M | $17.48M | $53.16M | $53.16M |
| Total Non-Current Liabilities | $8.49B | $9.40B | $9.34B | $9.27B | $9.27B |
| Long Term Debt and Capital Lease Obligation | $7.59B | $8.58B | $8.58B | $8.57B | $8.57B |
| -Long Term Debt | $7.59B | $8.58B | $8.58B | $8.57B | $8.57B |
| Employee Benefits | $774.45M | $713.22M | $648.67M | $577.87M | $577.87M |
| Other Non-Current Liabilities | $121.98M | $108.02M | $117.79M | $120.84M | $120.84M |
| Total Equity | $9.80B | $9.79B | $9.94B | $9.71B | $9.71B |
| Stockholders' Equity | $6.84B | $6.83B | $6.89B | $6.48B | $6.48B |
| Capital Stock | $108,000.00 | $108,000.00 | $108,000.00 | $106,000.00 | $106,000.00 |
| -Common Stock | $108,000.00 | $108,000.00 | $108,000.00 | $106,000.00 | $106,000.00 |
| Additional Paid-In Capital | $4.34B | $4.38B | $4.38B | $4.12B | $4.12B |
| Retained Earnings | $2.50B | $2.46B | $2.51B | $2.36B | $2.36B |
| Less: Treasury Stock | -$2.73M | -$2.72M | -$2.71M | -$2.61M | -$2.61M |
| Minority Interests | $2.96B | $2.95B | $3.05B | $3.24B | $3.24B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $686.08M | $728.46M | $718.23M | $2.49B | $827.15M |
| Net cash flow from continuing operations | $686.08M | $728.46M | $718.23M | $2.49B | $827.15M |
| Net Income from Continuing Operations | $266.64M | $81.49M | $468.26M | $1.32B | $356.91M |
| Gain/Loss from Continuing Operations | -$590.45M | -$669.70M | -$596.58M | -$2.31B | -$656.23M |
| Depreciation & Depletion & Amortization | $1.22M | $1.29M | $1.17M | $3.85M | $1.20M |
| Other Non-Cash Items | $941.03M | $826.00M | $925.16M | $3.40B | $932.16M |
| Change in Working Capital | -$111.14M | $86.69M | -$80.42M | -$17.15M | $48.51M |
| -Change in Receivables | -$4.46M | -$3.96M | $1.81M | -$2.36M | -$415,000.00 |
| -Change in Payables and Accrued Expense | -$95.56M | $90.60M | -$90.60M | -$4.99M | $53.24M |
| -Change in Other Current Assets | -$3.71M | $1.01M | -$4.91M | -$7.45M | -$3.31M |
| -Change in Other Current Liabilities | -$7.41M | -$954,000.00 | $13.28M | -$2.35M | -$1.01M |
| Net cash flow from investing | -$285.66M | -$229.72M | -$477.87M | -$1.61B | -$847.80M |
| Net Cash Flow from Continuing Investing Activities | -$285.66M | -$229.72M | -$477.87M | -$1.61B | -$847.80M |
| Net Business Purchase and Sale | $0.00 | – | – | -$74.42M | $0.00 |
| Net Investment Purchase and Sale | -$273.24M | -$216.19M | -$470.17M | -$1.36B | -$850.08M |
| Net Other Investing Changes | -$13.41M | -$317,000.00 | -$50.00M | -$280.26M | -$2.71M |
| Financing Cash Flow | -$698.74M | -$273.15M | -$272.67M | -$1.19B | -$299.60M |
| Net Cash Flow from Continuing Financing Activities | -$698.74M | -$273.15M | -$272.67M | -$1.19B | -$299.60M |
| Net Common Stock Issuance | -$86.34M | -$44.64M | -$50.10M | -$1.23B | -$80.54M |
| Cash Dividends Paid | -$105.12M | -$104.92M | -$104.49M | -$378.25M | -$94.34M |
| Net Other Financing Charges | -$127.29M | -$123.59M | -$118.08M | -$534.81M | -$124.72M |
| Ending Cash Balance | $513.66M | $811.99M | $586.40M | $618.70M | $618.70M |
| Net Change in Cash | -$298.33M | $225.59M | -$32.30M | -$310.33M | -$320.25M |
| Beginning Cash Balance | $811.99M | $586.40M | $618.70M | $929.03M | $938.94M |
| Free Cash Flow | $686.08M | $728.46M | $718.23M | $2.49B | $827.15M |
| Net Issuance Payments Of Debt | – | – | – | $954.48M | $0.00 |
No comments yet — be the first to weigh in on RPRX.
Sign in to join the discussion.